CONGRATULATIONS TO THIS YEAR’S ABSTRACT ACCEPTANCES!

CIO accepted a record-breaking number of abstracts and looks forward to receiving your submission for the 11th annual meeting taking place January 26-27, in Hollywood, Florida.

View the 2018 CIO Abstracts

Interested in submitting your cutting-edge research for CIO 2019? Please see below for important notification deadlines:

Important Deadlines: 

  • Submission Site Opens: end of August 2018
  • Submission Site Closes: October 2018
  • Acceptance/Wait List Notifications: November 2018
  • Withdrawal Deadline: November 2018
  • Registration/Intent to Present: November 2018

All submitted abstracts will undergo a blinded peer review and are reviewed for quality of research, educational or scientific content, logical presentation and impact on healthcare.

Accepted abstracts will be eligible for oral presentation, poster presentation, awards, online publication, and tuition support.

SUBMISSION INSTRUCTIONS & GUIDELINES 

The CIO Abstract Submission Portal will open at the end of August 2018

Click here to download the complete abstract submission guidelines, policies, and instructions.

Click here for additional information on style guidelines for abstract submissions.

SUBMISSION CATEGORIES 

Ablative Therapy
Chemoembolizaton/Drug-Eluting Embolics
Future Procedures
Hepatocellular Carcinoma
Imaging in Oncology
Liver Metastases
Lung Carcinoma
Molecular Targeted Therapy
Musculoskeletal Interventions
Other Organ Systems
Palliative Therapy
Radioembolization
Renal Cell Carcinoma
Surgical Oncology
Transcatheter Technologies
Other

QUESTIONS?

For questions regarding the abstract process, please contact Stephanie Weiss at sweiss@naccme.com or (609) 630-6209.